Form 4: Molina Healthcare Director Acquires Shares

Sentiment:

Insider Transaction Report


Molina Healthcare Director Leo Grohowski acquired 285 shares of common stock as part of his director compensation plan.

Summary

  • Leo P. Grohowski, a Director of Molina Healthcare, Inc. (MOH), acquired 285 shares of common stock.
  • The transaction occurred on October 1, 2025, and was made pursuant to a Rule 10b5-1 plan.
  • The shares were granted under the Issuer's 2025 Equity Incentive Plan as compensation for Grohowski's services as a Director.
  • The aggregate dollar value of the annual equity award for each director is set at $220,000, with $55,000 granted quarterly.
  • The grant of 285 shares was based on the closing price of Molina Healthcare's common stock, which was $192.79 on October 1, 2025.
  • Following this transaction, Leo Grohowski beneficially owns a total of 583 shares of Molina Healthcare common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it represents a routine, pre-planned director compensation grant, indicating stability and alignment of interests, without any negative implications.

Positives

  • The acquisition of shares by a director demonstrates continued alignment of management interests with shareholder interests.
  • The transaction is part of a pre-established equity incentive plan, indicating structured and transparent director compensation.

Future Outlook

The filing indicates that similar quarterly equity grants are expected to continue as part of the director compensation structure, with the next grant anticipated in the subsequent quarter.

Industry Context

This routine insider transaction reflects standard compensation practices for directors in publicly traded healthcare companies, aligning their interests with long-term company performance.

Related Party Transactions

  • The grant of common stock to Director Leo Grohowski constitutes a related party transaction as part of his compensation for services to Molina Healthcare.

Stakeholder Impact

  • Shareholders: The transaction demonstrates director alignment with shareholder interests through equity ownership.
  • Management: Reinforces the compensation structure for directors, linking their incentives to company performance.

Next Steps

  • Future quarterly equity awards to directors are expected to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day.

Key Dates

DateDescription
2025-03-28Date of execution of the Limited Power of Attorney for Section 16(a) filings by Leo Grohowski.
2025-10-01Transaction date for the acquisition of 285 shares of common stock by Leo Grohowski.
2025-10-02Date the Form 4 was signed by Jeff D. Barlow, attorney-in-fact for Leo Grohowski.

Recommendation

hold

This Form 4 filing details a routine, pre-scheduled stock grant to a director as part of their compensation. While it shows director alignment, it does not present new information or significant changes in the company's financial health or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, pending further material news or financial results.

Keywords

Molina Healthcare, MOH, Insider Transaction, Form 4, Director Compensation, Equity Incentive Plan, Stock Grant, Leo Grohowski

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.